Home
>
National Drug Code (NDC)
>
Spironolactone
Spironolactone - 65162-515-10 - (Spironolactone)
Drug Information of Spironolactone
| Product NDC: | 65162-515 |
| Proprietary Name: | Spironolactone |
| Non Proprietary Name: | Spironolactone |
| Active Ingredient(s): | 100 mg/1 & nbsp; Spironolactone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Spironolactone
| Product NDC: | 65162-515 |
| Labeler Name: | Amneal Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091426 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100802 |
Package Information of Spironolactone
| Package NDC: | 65162-515-10 |
| Package Description: | 100 TABLET in 1 BOTTLE (65162-515-10) |
NDC Information of Spironolactone
| NDC Code | 65162-515-10 |
| Proprietary Name | Spironolactone |
| Package Description | 100 TABLET in 1 BOTTLE (65162-515-10) |
| Product NDC | 65162-515 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Spironolactone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100802 |
| Marketing Category Name | ANDA |
| Labeler Name | Amneal Pharmaceuticals |
| Substance Name | SPIRONOLACTONE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA] |
